MWA Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
MWA Asset Management's VRTX Position: Q2 2026 in Review
MWA Asset Management reduced its Vertex Pharmaceuticals (VRTX) stake by 12% in Q2 2026, selling an estimated $222K and leaving 3,642 shares worth $1.81M. The position accounts for 0.82% of the portfolio, ranked #36.
MWA Asset Management first reported a position in VRTX in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.39M in Q1 2025. 1,762 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- MWA Asset Management held 3,642 shares of Vertex Pharmaceuticals worth $1.81M as of Q2 2026.
- MWA Asset Management sold 501 Vertex Pharmaceuticals shares in Q2 2026, an estimated $222K.
- Vertex Pharmaceuticals made up 0.82% of MWA Asset Management's portfolio in Q2 2026, its #36 holding.
- MWA Asset Management first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
- MWA Asset Management's Vertex Pharmaceuticals position peaked at $2.39M in Q1 2025.
- 1,762 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on MWA Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.